A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
Martin Kampmann’s work, supported by the National Institutes of Science (NIH), maps cellular “decision points” that determine ...
Yale researchers have created a new method for simulating “aging-like” chromosome errors in mouse eggs to better understand ...
Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...
In many cells of the human body, hair-like protrusions known as cilia act as antennae, allowing cells to receive signals from ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback